RMAX(RMAX)
RMAX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $289M | $287M |
| Low | $281M | $280M |
| High | $295M | $294M |
| EBITDA Avg | $125M | $124M |
| Low | $121M | $121M |
| High | $127M | $127M |
| EBIT Avg | $102M | $101M |
| Low | $99M | $99M |
| High | $104M | $104M |
| Net Income Avg | $25M | $27M |
| Low | $24M | $26M |
| High | $26M | $27M |
| EPS Avg | $1.23 | $1.31 |
| Low | $1.19 | $1.27 |
| High | $1.27 | $1.35 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $73M | $70M | $72M | $72M | $73M | $69M |
| Low | $72M | $68M | $71M | $71M | $72M | $68M |
| High | $74M | $71M | $73M | $73M | $74M | $70M |
| EBITDA Avg | $32M | $30M | $31M | $31M | $32M | $30M |
| Low | $31M | $29M | $31M | $31M | $31M | $30M |
| High | $32M | $31M | $32M | $32M | $32M | $30M |
| EBIT Avg | $26M | $25M | $25M | $26M | $26M | $25M |
| Low | $25M | $24M | $25M | $25M | $25M | $24M |
| High | $26M | $25M | $26M | $26M | $26M | $25M |
| Net Income Avg | $8M | $7M | $5M | $8M | $8M | $7M |
| Low | $8M | $6M | $5M | $8M | $8M | $7M |
| High | $9M | $7M | $5M | $8M | $9M | $7M |
| EPS Avg | $0.40 | $0.31 | $0.23 | $0.37 | $0.40 | $0.32 |
| Low | $0.39 | $0.29 | $0.22 | $0.36 | $0.39 | $0.32 |
| High | $0.40 | $0.33 | $0.23 | $0.38 | $0.41 | $0.33 |
| Analysts (Rev / EPS) | 2 / 2 | 3 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |